We report on the discovery of a new Milky Way companion stellar system located at (RA, Dec) = (22h10m43.15s, +14:56:58.8). The discovery was made using the eighth data release of SDSS after applying an automated method to search for overdensities in
the Baryon Oscillation Spectroscopic Survey footprint. Follow-up observations were performed using CFHT-MegaCam, which reveal that this system is comprised of an old stellar population, located at a distance of 31.9+1.0-1.6 kpc, with a half-light radius of r_h = 7.24+1.94-1.29 pc and a concentration parameter of c = 1.55. A systematic isochrone fit to its color-magnitude diagram resulted in log(age) = 10.07+0.05-0.03 and [Fe/H] = -1.58+0.08-0.13 . These quantities are typical of globular clusters in the MW halo. The newly found object is of low stellar mass, whose observed excess relative to the background is caused by 96 +/- 3 stars. The direct integration of its background decontaminated luminosity function leads to an absolute magnitude of MV = -1.21 +/- 0.66. The resulting surface brightness is uV = 25.9 mag/arcsec2 . Its position in the M_V vs. r_h diagram lies close to AM4 and Koposov 1, which are identified as star clusters. The object is most likely a very faint star cluster - one of the faintest and lowest mass systems yet identified.
The recent years have seen the emergence of diseases which have spread very quickly all around the world either through human travels like SARS or animal migration like avian flu. Among the biggest challenges raised by infectious emerging diseases, o
ne is related to the constant mutation of the viruses which turns them into continuously moving targets for drug and vaccine discovery. Another challenge is related to the early detection and surveillance of the diseases as new cases can appear just anywhere due to the globalization of exchanges and the circulation of people and animals around the earth, as recently demonstrated by the avian flu epidemics. For 3 years now, a collaboration of teams in Europe and Asia has been exploring some innovative in silico approaches to better tackle avian flu taking advantage of the very large computing resources available on international grid infrastructures. Grids were used to study the impact of mutations on the effectiveness of existing drugs against H5N1 and to find potentially new leads active on mutated strains. Grids allow also the integration of distributed data in a completely secured way. The paper presents how we are currently exploring how to integrate the existing data sources towards a global surveillance network for molecular epidemiology.
